Works matching IS 0008543X AND DT 2019 AND VI 125

Results: 686
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancer.

    Published in:
    2019
    By:
    • Martini, Alberto;
    • Jia, Rachel;
    • Ferket, Bart S.;
    • Waingankar, Nikhil;
    • Plimack, Elizabeth R.;
    • Crabb, Simon J.;
    • Harshman, Lauren C.;
    • Yu, Evan Y.;
    • Powles, Thomas;
    • Rosenberg, Jonathan E.;
    • Pal, Sumanta K.;
    • Vaishampayan, Ulka N.;
    • Necchi, Andrea;
    • Wiklund, N. Peter;
    • Mehrazin, Reza;
    • Mazumdar, Madhu;
    • Sfakianos, John P.;
    • Galsky, Matthew D.
    Publication type:
    journal article
    13

    Early squamous cell carcinoma of the oral tongue with histologically benign lymph nodes: A model predicting local control and vetting of the eighth edition of the American Joint Committee on Cancer pathologic T stage.

    Published in:
    2019
    By:
    • Sridharan, Shaum;
    • Thompson, Lester D. R.;
    • Purgina, Bibianna;
    • Sturgis, Charles D.;
    • Shah, Akeesha A.;
    • Burkey, Brian;
    • Tuluc, Madalina;
    • Cognetti, David;
    • Xu, Bin;
    • Higgins, Kevin;
    • Hernandez‐Prera, Juan C.;
    • Guerrero, Dominick;
    • Bundele, Manish M.;
    • Kim, Seungwon;
    • Duvvuri, Umamaheswar;
    • Ferris, Robert L.;
    • Gooding, William E.;
    • Chiosea, Simion I.;
    • Hernandez-Prera, Juan C
    Publication type:
    journal article
    14
    15
    16
    17
    18
    19

    Issue Information.

    Published in:
    Cancer (0008543X), 2019, v. 125, n. 18, p. 3087, doi. 10.1002/cncr.31618
    Publication type:
    Article
    20
    21
    22

    Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial.

    Published in:
    2019
    By:
    • Haddad, Robert;
    • Concha‐Benavente, Fernando;
    • Blumenschein, George;
    • Fayette, Jerome;
    • Guigay, Joel;
    • Colevas, A. Dimitrios;
    • Licitra, Lisa;
    • Kasper, Stefan;
    • Vokes, Everett E.;
    • Worden, Francis;
    • Saba, Nabil F.;
    • Tahara, Makoto;
    • Jayaprakash, Vijayvel;
    • Lynch, Mark;
    • Li, Li;
    • Gillison, Maura L.;
    • Harrington, Kevin J.;
    • Ferris, Robert L.;
    • Concha-Benavente, Fernando;
    • Blumenschein, George Jr
    Publication type:
    journal article
    23
    24
    25
    26

    A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.

    Published in:
    2019
    By:
    • Patil, Vijay Maruti;
    • Noronha, Vanita;
    • Joshi, Amit;
    • Agarwal, Jaiprakash;
    • Ghosh‐Laskar, Sarbani;
    • Budrukkar, Ashwini;
    • Murthy, Vedang;
    • Gupta, Tejpal;
    • Mahimkar, Manoj;
    • Juvekar, Shashikant;
    • Arya, Supreeta;
    • Mahajan, Abhishek;
    • Agarwal, Archi;
    • Purandare, Nilendu;
    • Rangarajan, Venkatesh;
    • Balaji, Arun;
    • Chaudhari, Sameer Vasant;
    • Banavali, Shripad;
    • Kannan, Sadhana;
    • Bhattacharjee, Atanu
    Publication type:
    journal article
    27
    28
    29
    30
    31
    32

    Patient‐reported and clinician‐reported chemotherapy‐induced peripheral neuropathy in patients with early breast cancer: Current clinical practice.

    Published in:
    Cancer (0008543X), 2019, v. 125, n. 17, p. 2945, doi. 10.1002/cncr.32175
    By:
    • Nyrop, Kirsten A.;
    • Deal, Allison M.;
    • Reeder‐Hayes, Kathryn E.;
    • Shachar, Shlomit S.;
    • Reeve, Bryce B.;
    • Basch, Ethan;
    • Choi, Seul Ki;
    • Lee, Jordan T.;
    • Wood, William A.;
    • Anders, Carey K.;
    • Carey, Lisa A.;
    • Dees, Elizabeth C.;
    • Jolly, Trevor A.;
    • Kimmick, Gretchen G.;
    • Karuturi, Meghan S.;
    • Reinbolt, Raquel E.;
    • Speca, JoEllen C.;
    • Muss, Hyman B.
    Publication type:
    Article
    33
    34

    Oral arsenic trioxide incorporation into frontline treatment with all‐trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5‐year prospective study.

    Published in:
    Cancer (0008543X), 2019, v. 125, n. 17, p. 3001, doi. 10.1002/cncr.32180
    By:
    • Gill, Harinder;
    • Kumana, Cyrus R.;
    • Yim, Rita;
    • Hwang, Yu‐Yan;
    • Chan, Thomas S. Y.;
    • Yip, Sze‐Fai;
    • Lee, Harold K. K.;
    • Mak, Vivien;
    • Lau, June S. M.;
    • Chan, Chi‐Chung;
    • Kho, Bonnie;
    • Wong, Raymond S. M.;
    • Li, Wa;
    • Lin, Shek‐Yin;
    • Lau, Chi‐Kuen;
    • Ip, Ho‐Wan;
    • Leung, Rock Y. Y.;
    • Lam, Clarence C. K.;
    • Kwong, Yok‐Lam
    Publication type:
    Article
    35
    36
    37
    38

    Do contemporary imaging and biopsy techniques reliably identify unilateral prostate cancer? Implications for hemiablation patient selection.

    Published in:
    Cancer (0008543X), 2019, v. 125, n. 17, p. 2955, doi. 10.1002/cncr.32170
    By:
    • Johnson, David C.;
    • Yang, Jason J.;
    • Kwan, Lorna;
    • Barsa, Danielle E.;
    • Mirak, Sohrab A.;
    • Pooli, Aydin;
    • Sadun, Taylor;
    • Jayadevan, Rajiv;
    • Zhou, Steve;
    • Priester, Alan M.;
    • Natarajan, Shyam;
    • Bajgiran, Amirhossein M.;
    • Shakeri, Sepideh;
    • Sisk, Anthony;
    • Felker, Ely R.;
    • Raman, Steven S.;
    • Marks, Leonard S.;
    • Reiter, Robert E.
    Publication type:
    Article
    39
    40

    Issue Information.

    Published in:
    Cancer (0008543X), 2019, v. 125, n. 17, p. 2897, doi. 10.1002/cncr.31617
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50